
Ingenix raises €13m to scale AI drug development model
AI company Ingenix has announced it has raised €13 million to scale its drug development model. Ingenix says its Biological Reasoning Engine overcomes structural problems in AI drug development, integrating best-in-class models across modalities and biological scales. The model was applied to a dual-payload ADC prioritisation… Read More











